Nearly half of the cases (48%) had an APL-like phenotype represented by CD34(−)/HLA-DR(−)/MPO(str+), which could predict the presence of TET2 or IDH1/2 mutations, a result in line with our findings. The gene discussed is MPO; the disease is acute promyelocytic leukemia.